RhGM-CSF as Adjuvant Immunotherapy in Treating Stage III Colon Cancer

NCT02466906 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: rhGM-CSF
DRUG: placebo

Sponsor

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences